Buy Aceon | Cheap Aceon | Buy Aceon Online
Buy Aceon | Cheap Aceon | Buy Aceon Online
FAQ
Search
Memberlist
Usergroups
Galleries
Register
Profile
Log in to check your private messages
Log in
Buy Aceon | Cheap Aceon | Buy Aceon Online Forum Index
->
Buy Aceon | Cheap Aceon | Buy Aceon Online
Post a reply
Username
Subject
Message body
Emoticons
View more Emoticons
Font colour:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
White
Black
Font size:
Tiny
Small
Normal
Large
Huge
Close Tags
Options
HTML is
OFF
BBCode
is
ON
Smilies are
ON
Disable BBCode in this post
Disable Smilies in this post
Confirmation code: *
All times are GMT + 2 Hours
Jump to:
Select a forum
Jakaś kategoria
----------------
Buy Aceon | Cheap Aceon | Buy Aceon Online
Topic review
Author
Message
cheapbag214s
Posted: Mon 22:06, 18 Nov 2013
Post subject: test and manufacture biosimilar products
Samsung Bioepis, Merck to work together in biolsimilar sector
SEOUL, Feb. 21 () -- South Korea's Samsung Bioepis and U.S. pharmaceutical giant Merck have agreed to work together in the biosimilar sector.Samsung Bioepis, a $300 million joint venture between Samsung Biologics and U.S. firm Biogen Idec., said under the deal with Merck, it will develop, test and manufacture biosimilar products,[url=http://www.parajumpersjackenoutlet.de/]parajumpers damen[/url], and that Merck will use its global distribution network to promote and sell biosimilars, the company said in a news release.The U.S. Food and Drug Administration defines biosimilars as products that are shown to be highly similar to or interchangeable with an FDA-licensed biological product. Biological products are therapies used to treat health conditions."Samsung Bioepis has been building the capabilities needed to develop high-quality biosimilars," Chief Executive Officer Christopher Hansung Ko said."With this development and commercialization agreement,[url=http://www.isabelmarantsneakersbootss.com/]isabel marant online[/url], Samsung takes a significant step toward becoming a major player in the biopharmaceutical industry."Merck's announcement on its website quoted Rich Murray, its senior vice president for biologics and vaccines research, as saying the combination of his company's global commercial presence and Samsung Bioepis' biologic development and manufacturing capabilities "positions the two companies well to increase access to biosimilars to improve human health."Merck said Samsung Bioepis will receive an upfront payment, product supply income and will be eligible for additional payments associated with pre-specified clinical and regulatory milestones.
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2005 phpBB Group
Regulamin